دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 1 نویسندگان: R. G. Fairchild, V. Benary, J. Kalef-Ezra, S. K. Saraf, R. M. Brugger, A. Shih (auth.), Barry J. Allen, Douglas E. Moore, Baiba V. Harrington (eds.) سری: ISBN (شابک) : 9781461364948, 9781461533849 ناشر: Springer US سال نشر: 1992 تعداد صفحات: 640 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 43 مگابایت
کلمات کلیدی مربوط به کتاب پیشرفت در درمان جذب نوترون برای سرطان: انکولوژی، پزشکی هسته ای، اولتراسوند، آناتومی حیوانات / مورفولوژی / بافت شناسی، علوم گیاهی
در صورت تبدیل فایل کتاب Progress in Neutron Capture Therapy for Cancer به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب پیشرفت در درمان جذب نوترون برای سرطان نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
علیرغم پیشرفتهای بسیاری که در تشخیص و درمان سرطان انجام شده است، میزان مرگ و میر هنوز حدود نصف میزان بروز است. با این حال، شانس به طور مساوی توزیع نشده است. پیش آگهی برخی از سرطان ها خوب است، اما برای برخی دیگر، تعداد کمی از بیماران 12 ماه زنده می مانند. این گروه دوم از سرطان ها با تمایل به انتشار سلول های بدخیم در اندام میزبان مشخص می شوند. درجه جراحی ممکن ممکن است به دلیل ماهیت بحرانی اندام محدود شود و شیمی درمانی و رادیوتراپی فقط دارای ارزش تسکینی هستند. در برخی موارد متاستازهای سیستمیک رخ می دهد، اما در موارد دیگر، عدم دستیابی به کنترل موضعی منجر به مرگ می شود. اولین در میان این سرطان ها، تومورهای مغزی درجه بالا، آستروسیتوم 3،4 و گلیوبلاستوما مولتی فرم هستند. کنترل موضعی این تومورها باید منجر به درمان شود. سرطان های دیگر ملانوم متاستاتیک به مغز، که درمان تسکینی مفیدی برای آن ها هنوز در دسترس نیست، و سرطان لوزالمعده که کنترل موضعی آن در مراحل اولیه می تواند پیش آگهی بهتری ایجاد کند. بیماران مبتلا به این سرطان ها زمینه کمی برای امید دارند. هدف اصلی ما معکوس کردن این وضعیت با درمان جذب نوترون (NCT) است. هدف از این چهارمین سمپوزیوم تسریع روزی است که در آن بیماران مبتلا به این سرطان ها می توانند به طور منطقی به بهبودی قابل توجه امیدوار باشند. اولین سمپوزیوم در مورد NCT در سال 1983 در بوستون برگزار شد، پس از آن در توکیو در سال 1985 و برمن، آلمان در سال 1988 برگزار شد.
Despite the many advances made in the diagnosis and therapy of cancer, the mortality rate is still about half that of the incidence rate. However, the odds are not evenly distributed. Prognosis for some cancers is good, but for others, few patients will survive 12 months. This latter group of cancers is characterised by a proclivity to disseminate malignant cells in the host organ. The degree of surgery possible may be limited by the critical nature of the organ, and chemotherapy and radiotherapy are of palliative value only. In some cases systemic metastases occur, but in other cases, failure to achieve local control results in death. First among these cancers are the high grade brain tumours, astrocytoma 3,4 and glioblastoma multiforme. Local control of these tumours should lead to cure. Other cancers melanoma metastatic to the brain, for which a useful palliative therapy is not yet available, and pancreatic cancer for which localised control at an early stage could bring about improved prognosis. Patients with these cancers have little grounds for hope. Our primary objective is to reverse this situation with Neutron Capture Therapy (NCT). The purpose of this fourth symposium is to hasten the day whereby patients with these cancers can reasonably hope for substantial remissions. The first symposium on NCT was held in Boston in 1983, followed by Tokyo in 1985 and Bremen, Germany in 1988.
Front Matter....Pages i-xxxi
An Optimized Epithermal Neutron Beam for Neutron Capture Therapy (NCT) at the Brookhaven Medical Research Reactor (BMRR)....Pages 1-6
The Petten BNCT Project....Pages 7-12
The Idaho Power Burst Facility/Boron Neutron Capture Therapy (PBF/BNCT) Program Overview....Pages 13-20
The Neutron Capture Therapy Research Program at New England Medical Center and the Massachusetts Institute of Technology....Pages 21-26
Nct Program at the University of Missouri-Columbia....Pages 27-29
Goals of the european collaboration on Boron neutron capture therapy....Pages 31-36
Critique of Mit Workshop on Neutron Beam Design, Development and Performance for Neutron Capture Therapy....Pages 37-40
Programme for BNCT with Accelerator-Produced KeV Neutrons and Related Chemical and Biological Studies....Pages 41-52
Performance of the Currently Available Epithermal Neutron Beam at the Massachusetts Institute of Technology Research Reactor (MITR-II)....Pages 53-56
A Compact Triga Reactor for Boron Neutron Capture Therapy....Pages 57-62
Design, Construction and Installation of an Epithermal Neutron Beam for BNCT at the High Flux Reactor Petten....Pages 63-66
Modelling an Epithermal Neutron Beam for a Dido Type Reactor Using Mcnp - A Monte Carlo Code....Pages 67-69
Mcnp Calculations for the Design and Characterisation of the Petten BNCT Epithermal Neutron Beam....Pages 71-73
Monte-Carlo Calculation Results for the Epithermal Neutron Beam at the Brookhaven Medical Reactor....Pages 75-78
Design Considerations for the Proposed Hifar Thermal and Epithermal Neutron Capture Therapy Facilities....Pages 79-82
Neutron Beam Parameters on LVR-15 Reactor for Neutron Capture Therapy....Pages 83-86
Study on the Best Design of Neutron Irradiation Facility for BNCT....Pages 87-90
Studsvik Thermal Neutron Facility....Pages 91-93
Effective Thermal Neutron Collimation for Neutron Capture Therapy Using Neutron Absorption and Scattering Reactions....Pages 95-99
Reevaluation of Thermal Neutron Field of the KUR Heavy Water Facility for Biomedical Uses (Optimization of Bismuth, Heavy Water and Graphite Layers)....Pages 101-105
Design of an Accelerator-Based Epithermal Neutron Beam for Boron Neutron Capture Therapy....Pages 107-112
An Integrated Neutronic and Thermal-Hydraulic Design Study for an Accelerator Neutron Irradiation Facility....Pages 113-117
An Epithermal Neutron Source for Bnct Using a Tandem Cascade Accelerator....Pages 119-122
Accelerator Based Neutron Sources for Neutron Capture Therapy....Pages 123-127
Neutrons for Capture Therapy Produced by 72 MeV Protons....Pages 129-132
A Monte Carlo Study of Ideal Beams for Epithermal Neutron Beam Development for Boron Neutron Capture Therapy....Pages 133-136
Analytical Dosimetry for Spontaneous Tumor Dogs Receiving Boron Neutron Capture Therapy....Pages 137-140
Some Physical Factors Influencing the Distributions of Thermal Neutrons and Gamma-Rays in a Phantom....Pages 141-143
Characterization of the Bmrr and PBF Epithermal-Neutron Beams in Phantom Using Three-Dimensional Deterministic Radiation Transport Theory....Pages 145-149
Beyond the Epithermal-Neutron Beam: The Analytical Physicist’s Role....Pages 151-154
Measurements of Lineal Energy Spectra for Neutron Capture Therapy Using a Boron Doped Let Chamber....Pages 155-157
Dose Measurements and Calculations in the Epithermal Neutron Beam at the Brookhaven Medical Research Reactor (BMRR)....Pages 159-161
Review of Techniques Developed at Harwell Laboratory for Neutron and Gamma-Ray Characterisation of Filtered Neutron Beams for Boron Neutron Capture Therapy....Pages 163-165
Relation Between Tolerance Dose of Skin and Boron-10 Concentration in Neutron Capture Therapy for Cutaneous Melanoma....Pages 167-171
Treatment Planning for Neutron Capture Therapy of Glioblastoma Multiforme Using an Epithermal Neutron Beam from the Mitr-II Research Reactor and Monte Carlo Simulation....Pages 173-177
Enhancement of Tumor Dose by the Gadolinium Neutron Capture Reaction in Cf-252 Brachytherapy....Pages 179-182
Gadolinium as a Neutron Capture Therapy Agent....Pages 183-186
Boron Neutron Capture Enhancement in Cf-252 Brachytherapy....Pages 187-189
Comparison of Dose Distributions with 10 Boron Augmented Sources of 252 Cf Obtained by Monte Carlo Simulation and by Experimental Measurement....Pages 191-194
Boron Neutron Capture Enhancement of the Tumor Dose in Fast Neutron Therapy Beams....Pages 195-198
Neutron Capture Reactions in a d(14)+Be Fast Neutron Beam....Pages 199-202
The Potential of Internal Neutron Sources in Capture Therapy....Pages 203-205
Carboranyl Precursors of Nucleic Acids--Potential DNA Probes for BNCT....Pages 207-210
Boron Containing Nucleic Acids....Pages 211-213
Preparation of New Boron Compounds with Potential for Application in 10 B NCT: Derivatives of Monocarbon Carboranes....Pages 215-217
Molecular Design and Synthesis of B-10 Carriers for Neutron Capture Therapy....Pages 219-222
Synthesis and Properties of Tetrakis-Carborane-Carboxylate Esters of 2,4-BIS-(α,β-Dihydroxyethyl) Deuteroporphyrin IX....Pages 223-226
Carborane Compounds for Neutron Capture Therapy of Malignant Melanoma....Pages 227-230
Synthesis of 10 B- and 157 Gd-Labelled DNA Ligands for Neutron Capture Therapy....Pages 231-233
Behaviour of the Biologically Active Sulfhydryl Group of Mercaptoundecahydro- closo -Dodecaborate(2-) (Mercaptoborate) Studied by ESR and Polarography....Pages 235-238
Synthesis and Biological Properties of Boronated Thioureas as Highly Selective Tumor Seekers for Melanoma....Pages 239-242
Complex Formation of Phenylboronic Acid Derivatives with Aldopentoses and Oligosaccharides....Pages 243-246
Optical Purity Determination of D,L-Boronophenylalanine by High Performance Liquid Chromatography with a Chiral Mobile Phase....Pages 247-250
Enantioselective Synthesis of L-(-)-4-Boronophenylalanine (L-BPA) by Asymmetric Catalytic Hydrogenation....Pages 251-254
Complete Separation of Racemic p-Boronophenylalanine by High Performance Liquid Chromatography with Crown Ether-Coated Reversed-Phase Packings....Pages 255-257
Liposomal Delivery of Boron for BNCT....Pages 259-264
Delivery of Boron-10 for Neutron Capture Therapy by Means of Monoclonal Antibody - Starburst Dendrimer Immunoconjugates....Pages 265-268
Antibody Targeting of Boron Compounds....Pages 269-271
Application of Boronated Anti-Cea Immunoliposome to Boron Neutron Capture Therapy....Pages 273-275
Studies Related to Antibody-Mediated Boron Delivery for BNCT....Pages 277-281
Continuous Measurement of Boron-10 Concentration in Rabbit Brain Tissue and Blood Using Prompt Gamma-Ray Spectrometry....Pages 283-287
Bioanalytical Investigations on Experimental BNCT with Cold Neutrons at the Jülich Research Reactor FRJ-2, Status Report....Pages 289-291
Boron Concentration Measurements for the Petten BNCT Project....Pages 293-296
Flow Injection for Sample Introduction into Inductively Coupled Plasma for the Determination of Boron in Biological Samples....Pages 297-300
Boron-10 Prompt Gamma Analysis Using a Diffracted Neutron Beam....Pages 301-304
Determination of Boron Concentration by Means of Direct Current Plasma - Atomic Emission Spectroscopy....Pages 305-308
Rapid Spectrophotometric Determination of Boron in Biological Tissue with Alkali Fusion Decomposition....Pages 309-312
Phantom Experiment and Calculation for in Vivo 10 B Analysis by Prompt Gamma-Ray Spectroscopy at the Musashi Reactor....Pages 313-315
Determination of Boron Concentration in Tissues by Means of Alpha Autoradiography....Pages 317-320
A New Boron MRI Method for Imaging BNCT Agents in Vivo....Pages 321-323
In Vivo Pharmacokinetic Evaluation of Boron Compounds Using Magnetic Resonance Spectroscopy and Imaging....Pages 325-329
Intracellular Boron Uptake and Distribution of BSH and BPA Determined Using Ion Microscopy....Pages 331-333
Uptake of Boronated Monoclonal Antibodies by Melanoma Cells Visualised by Track Etch Autoradiography and Electron Energy Loss Spectroscopy....Pages 335-338
Interaction between Boron Containing Compounds and Serum Albumin Observed by Nuclear Magnetic Resonance....Pages 339-343
The Necessity of Stochastic Radiobiology in BNCT or What is the RBE of the 10 B(n,α) 7 Li Reaction....Pages 345-348
Enhancement of Thermal Neutron Induced Killing Effect on Hela Cells Containing Boron-10 Nucleic Acid Derivatives....Pages 349-351
Further in Vitro Radiobiological Analysis on 10 B-BPA BNCT of Malignant Melanoma: Correlation of Determined 10 B-Content and Cell Killing Effect....Pages 353-356
157 Gd-Neutron Capture: Potential of 157 Gd-Labelled DNA Ligands for Neutron Capture Therapy....Pages 357-360
Gadolinium-Neutron Capture Reactions: A Radiobiological Assay....Pages 361-363
In Vitro Biological Efficacy of Boronated Low Density Lipoproteins for NCT....Pages 365-368
In Vitro Incorporation of Boronophenylalanine by Amelanotic and Melanotic Murine and Human Malignant Melanoma Cell Lines....Pages 369-371
Studies on the Uptake of Para-Boronophenylalanine in Melanoma Cells....Pages 373-376
Studies to Use Fission Neutrons in BNCT for Deeper Tumor Lesion....Pages 377-380
Intracellular Distribution of Various Boron Compounds in Rat 9L Gliosarcoma Cells....Pages 381-385
In Vitro Evaluation of 10 B-BPA for Melanoma at Moata - Joint Work between Japan and Australia BNCT Research Teams....Pages 387-390
Thermal Neutron Capture Therapy (NCT) Using 10 B-Conjugated Antimelanoma Antibodies: Quantification of 10 B on Cultured Human Melanoma Cells....Pages 391-394
Ultrastructural Changes in Tumour Cells Following Boron Neutron Capture Therapy....Pages 395-397
Dose Modification by Neutron Capture in Cell Culture Using a 1 MeV Mean Energy Fission Neutron Beam....Pages 399-401
Thermal Neutron Induced Decomposition and Inactivation of Several Biomolecules....Pages 403-405
Killing Effects of Gadolinium Neutron Capture Reaction on Brain Tumors....Pages 407-410
Spontaneous Canine Oral Melanoma: A Large Animal Model for BNCT....Pages 411-415
Dose-Response Analysis for Boron Neutron Capture Therapy of the B16 Murine Melanoma Using p-Boronophenylalanine....Pages 417-419
Increased Selective 10 B-Uptake by Malignant Melanoma Using Systemic Administration of 10 B 1 -BPA·Fructose Complex....Pages 421-424
Local Control of Murine Melanoma Xenografts in Nude Mice by Neutron Capture Therapy....Pages 425-428
A Rat Model for the Treatment of Melanoma Metastatic to the Brain by Means of Neutron Capture Therapy....Pages 429-434
Radiobiology of Boron Neutron Capture Therapy: Problems with the Concept of Relative Biological Effectiveness....Pages 435-437
In Vivo Cellular Pharmacology on the Selective Affinity of 10 B 1 -BPA for Malignant Melanoma....Pages 439-442
Comparative Pharmacokinetics and Distribution Studies of Boric Acid, L-BPA and BSH in Two Murine Tumour Models....Pages 443-445
Evaluation of Response of Hepatocytes(in Vivo) to Thermal Neutron Irradiation by Micronucleus Assay....Pages 447-450
Liposomes as Carriers of Boronated Thiouracils for NCT of Melanoma....Pages 451-454
Biodistribution, Toxicity and Efficacy of a Boronated Porphyrin for Boron Neutron Capture Therapy....Pages 455-457
Basic Studies in Bnct — Tolerance to Heavy Water....Pages 459-462
Boron Neutron Capture Therapy of Ocular Melanoma and Intracranial Glioma Using p-Boronophenylalanine....Pages 463-468
A Quantitative Study on Pharmacokinetics and Biodistribution of BSH in a Rat Glioma Model....Pages 469-473
Biodistribution and Pharmacokinetics of p -Boronophenylalanine in C57BL/6 Mice with GL261 Intracerebral Tumors, and Survival Following Neutron Capture Therapy....Pages 475-478
A Large Animal Model for Boron Neutron Capture Therapy....Pages 479-484
Radiobiology Studies at Petten: Status on Cell Culture, Mice and Dog Experiments....Pages 485-488
The Biodistribution of Boron in Normal Canine Tissues Following Borocaptate Sodium Administration and the Effect of Plasma Exchange....Pages 489-492
Distribution of a Boronated Porphyrin (BTPP) in Osteosarcoma Bearing Nude Mice....Pages 493-496
Feasibility Study of Boron Neutron Capture Therapy for Inoperable Liver Cancers....Pages 497-500
Tumour Localization of Boronated Porphyrins in an Intracerebral Model of Glioma....Pages 501-505
Acute and Late Reactions Following Boron Neutron Capture Epithermal-Neutron Therapy in Dogs with Spontaneous Brain Tumors....Pages 507-510
Tolerance Limits of the Normal Skin Treated by a Single Thermal Neutron Capture Therapy....Pages 511-514
Qualitative Dose Response of the Normal Canine Head to Epithermal Neutron Irradiation with and Without Boron Capture....Pages 515-519
Boron Neutron Capture Therapy: The Radiation Response of Rat Skin and Spinal Cord....Pages 521-523
Influence of BNCT Radiations on the Blood-Brain Barrier in Terms of Boron-10 Uptake....Pages 525-529
Blood-Brain Barrier and Its Manipulation: Implications for Neutron Capture Therapy....Pages 531-536
The Biodistribution of Boron in Canine Spontaneous Intracranial Tumors Following Borocaptate Sodium Infusion....Pages 537-540
Regional and Total Body Dose Following BNCT Epithermal Head Irradiation: Biologic and Dosimetric Evaluation....Pages 541-544
Biodistribution of Boron Sulfhydryl (BSH) in Humans: A Quality Control of Analytical Methods * ....Pages 545-547
Pharmacokinetics of Boron Sulfhydryl (BSH) in Patients with Intracranial Tumours * ....Pages 549-550
Biodistribution of Boron Sulfhydryl (BSH) in Patients with Intracranial Tumors * ....Pages 551-556
The Distribution of BSH in Patients with Malignant Glioma....Pages 557-560
Clinical Results of Boron Neutron Capture Therapy....Pages 561-568
Clinical Experience of Bnct for Brain Tumours at Jaeri....Pages 569-576
Advances in the Control of Human Cutaneous Primary and Metastatic Melanoma by Thermal Neutron Capture Therapy....Pages 577-583
A Proposal for Clinical Pilot Studies for Boron Neutron Capture Therapy....Pages 585-588
Proposed Clinical Approach to Bnct....Pages 589-591
Clinical Experience of Bnct for Brain and Skin Tumours at Kyoto University Reactor....Pages 593-596
The State of the Art for Radiotherapy for Brain Tumors: Nonconventional Fractionation, Heavy Ions, and Fast-Neutron Therapy....Pages 597-603
Incidence and Survival of Cancers for Which Available Treatments Appear Ineffective....Pages 605-608
Limitations in the Conventional Treatment of Cerebral Metastases from Melanoma....Pages 609-612
Photodynamic Therapy of Brain Tumours....Pages 613-617
CF-252 Neutron Brachytherapy, Neutron Capture Therapy and Teletherapy for Melanoma and Malignant Gliomas....Pages 619-624
Problems of Dose Fractionation in BNCT....Pages 625-645
Back Matter....Pages 647-668